Skip to content
PatientMatchFind trials

Screener

Eligibility screening

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

1 US site in MD

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.